Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Urol. 2012 Nov;9(11):638-51. doi: 10.1038/nrurol.2012.177. Epub 2012 Oct 2.

Treatment options for intrinsic sphincter deficiency.

Author information

  • 1Sol and Margaret Berger Department of Urology, Beth Israel Medical Center Phillips Ambulatory Care Center, New York, NY 10003, USA. sshah@chpnet.org

Abstract

Type III stress urinary incontinence (SUI) is generally defined as a condition that involves intrinsic sphincter deficiency (ISD). Although the clinical parameters for ISD are loosely defined as a Valsalva leak-point pressure <60 cmH(2)O or a maximal urethral closure pressure <20 cmH(2)O, consensus is lacking. As a result, studies evaluating the success of any treatment for ISD are difficult to interpret. Regardless, several studies over the past 20 years have evaluated a number of surgical and nonsurgical treatments specifically for SUI caused by ISD. Surgical options include retropubic suspension, needle suspensions, various types of suburethral slings and the artificial urinary sphincter, whereas nonsurgical options include urethral bulking agents. Assessing urethral function (specifically, leak-point pressure or maximal urethral closure pressure) and urethral hypermobility will enable treating physicians to determine the ideal solution for individual patients, especially as no standardized treatment for ISD exists.

PMID:
23027065
DOI:
10.1038/nrurol.2012.177
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center